![Donald Lee Drakeman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Lee Drakeman
Director Ejecutivo en
GenPharm International LLC
.
Perfil
Donald Lee Drakeman was the founder of Genmab A (1998) and Medarex, Inc. (1987) where the title held was President & Chief Executive Officer from 1987 to 2006.
Current jobs include President & Chief Executive Officer at GenPharm International LLC, Chairman at New Jersey Commission on Science & Technology, Director at Gem Pharmaceuticals LLC, and Venture Partner at Advent Venture Partners LLP since 2007.
Former jobs include Chairman at Celldex Therapeutics, Inc. (Old), Independent Director at Zymeworks BC, Inc., Director-Executive Board at 4-Antibody AG, Director at IDM Pharma, Inc., and Faculty Member at Princeton University.
Education includes a graduate degree from The Trustees of Columbia University in The City of New York (1979), an undergraduate degree from Dartmouth College (1975), and a doctorate from Princeton University (1988).
Cargos activos de Donald Lee Drakeman
| Empresas | Cargo | Inicio |
|---|---|---|
GenPharm International LLC
 GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Director Ejecutivo | - |
New Jersey Commission on Science & Technology
 New Jersey Commission on Science & Technology General GovernmentGovernment Engages in development and oversight of policies and programs promoting science and technology research and entrepreneurship | Presidente | - |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Inversor de Capital Privado | 01/01/2007 |
Gem Pharmaceuticals LLC
 Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company develops proprietary anthracycline derivatives | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Donald Lee Drakeman.
| Empresas | Cargo | Fin |
|---|---|---|
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Director/Miembro de la Junta | 01/06/2007 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Director Ejecutivo | 05/11/2006 |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| GENMAB A/S | Fundador | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Director/Miembro de la Junta | - |
Formación de Donald Lee Drakeman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
97
Relaciones de 1er grado
13
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
New Jersey Commission on Science & Technology
New Jersey Commission on Science & Technology General GovernmentGovernment Engages in development and oversight of policies and programs promoting science and technology research and entrepreneurship | Government |
Gem Pharmaceuticals LLC
Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company develops proprietary anthracycline derivatives | Health Technology |
- Bolsa de valores
- Insiders
- Donald Lee Drakeman
